Closing of public offering of common stock
14 Jan 2020 Aptinyx Announces Closing of Public Offering of Common Stock and Full to purchase additional shares, at a public offering price of $3.00 per 26 Sep 2019 VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares. 16 Apr 2002 As of the close of business today, the Company will have 28,390,287 common shares outstanding. The offering resulted in net proceeds to the 8 Apr 2019 (Nasdaq: TCDA) today announced the closing of its previously announced public offering of 6,440,000 shares of its common stock at a public
18 Feb 2020 333-228970) relating to the public offering of the shares of common stock described above was previously filed with and declared effective by
MEI Pharma Announces Closing of Public Offering of Common Stock By Published: Dec 19 , 2019 announced today that it has closed the underwritten public offering of 32,343,750 shares of A shelf registration statement on Form S-3 (File No. 333-217106) relating to the public offering of the shares of common stock described above was declared effective by the Securities and Exchange Cerus Corporation CERS, +1.99% announced today the closing of a registered underwritten public offering of its common stock, which included the sale of additional shares of common stock upon full InVivo Therapeutics Holdings Corp. NVIV, -5.04% today announced the closing of its previously announced public offering of 7,000,000 shares of its common stock, par value $0.00001 per share, at a --Matinas BioPharma Holdings, Inc.--, a clinical-stage biopharmaceutical company, today announced the closing of its underwritten registered public offering of 32,260,000 shares of its common
Cerus Corporation CERS, +1.99% announced today the closing of a registered underwritten public offering of its common stock, which included the sale of additional shares of common stock upon full
Seelos Therapeutics Announces Closing of Public Offering of Common Stock. PRESS RELEASE GlobeNewswire underwritten public offering of 6,666,667 shares of its common stock, at a price to the A shelf registration statement on Form S-3 (Registration No. 333-230448) relating to the public offering of the shares of common stock described above was previously filed with the Securities and Immunomedics Announces Closing of Public Offering of Common Stock LLC and Jefferies LLC are acting as joint book-running managers for the offering. The shares of common stock are being offered Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares By Published: Feb 3, 2020 6:00 p.m. ET.
23 Jul 2018 (Nasdaq: BLUE) today announced the closing of its previously announced underwritten public offering of 3,892,308 shares of its common stock,
16 Feb 2018 6,325,000 shares of common stock at a public offering price of $8.00 per share were issued and sold in the offering, which includes 825,000 4 Mar 2019 Alder BioPharmaceuticals, Inc. Announces Closing of Public Offering and Private Placement of Common Stock and Exercise in Full of Option to A shelf registration statement on Form S-3 (Registration No. 333-230448) relating to the public offering of the shares of common stock described above was previously filed with the Securities and Immunomedics Announces Closing of Public Offering of Common Stock LLC and Jefferies LLC are acting as joint book-running managers for the offering. The shares of common stock are being offered
13 Feb 2020 rare diseases, announced today the closing of its previously announced underwritten public offering of 6,666,667 shares of its common stock,
3 Feb 2020 Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares. 18 Feb 2020 333-228970) relating to the public offering of the shares of common stock described above was previously filed with and declared effective by 13 Feb 2020 rare diseases, announced today the closing of its previously announced underwritten public offering of 6,666,667 shares of its common stock,
Cerus Corporation CERS, +1.99% announced today the closing of a registered underwritten public offering of its common stock, which included the sale of additional shares of common stock upon full